stockrow
Saturday 7 November 2026
Export RHEP’s income statement to Excel — free account
Adcare Health Systems Inc
RHEP Healthcare Medical Care Facilities
Adcare Health Systems Inc’s revenue for fiscal 2025 (year ended December 2025) was $53.2 million, up 189.9% from fiscal 2024.
- Revenue
- +143.0%
- EPS
- +70.6%
- Free cash flow
- +224.5%
- Total debt
- −13.0%
Quarter to June 2026, against a year earlier
1.00
0.00
0.00%
Follow RHEP
Alert me
| Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 2.56 |
Piotroski F-Score |
4 | 5 | 3 | 5 | 5 | 3 | 2 | 5 | 5 | 5 |
Altman Z-Score |
(0.75) | (1.14) | (1.43) | (1.00) | (1.14) | (1.09) | (2.22) | (1.36) | (1.90) | (0.93) |
P/S ratio |
1.12 | 0.15 | 0.12 | 0.12 | 0.34 | 0.29 | 0.15 | 0.23 | 0.16 | 0.07 |
P/FCF ratio |
2.30 | 1.32 | 2.59 | 0.47 | 7.15 | 1.64 | 0.00 | 1.42 | 2.05 | 0.52 |
Altman Z″-Score (non-manufacturers) |
(2.98) | (3.63) | (3.76) | (2.60) | (2.85) | (3.00) | (6.33) | (3.19) | (6.09) | (4.52) |
P/Operating CF |
(11.30) | 2.42 | 2.03 | 1.95 | 15.94 | 10.00 | (3.85) | 15.49 | 3.04 | (2.84) |
Beneish M-Score |
(2.09) | (3.11) | (3.27) | (1.20) | (1.33) | (2.29) | (1.47) | (4.29) | (1.25) | (0.24) |
P/B ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Sales |
3.31 | 2.69 | 3.58 | 2.47 | 3.50 | 2.22 | 1.56 | 2.52 | 2.74 | 0.79 |
EV/EBITDA |
8.41 | 6.53 | 17.87 | 5.46 | 11.57 | 11.33 | 0.00 | 28.69 | 21.84 | 10.79 |
EV/Operating CF |
(26.79) | 13.13 | 58.54 | 20.74 | 47.51 | 12.08 | (15.61) | 11.66 | 25.82 | (18.63) |
EV/FCF |
6.78 | 23.10 | 78.13 | 9.89 | 72.81 | 12.39 | (14.48) | 15.72 | 35.50 | 6.13 |
Quick Ratio |
0.72 | 0.19 | 0.72 | 1.31 | 1.83 | 1.37 | 0.88 | 0.85 | 0.29 | 0.52 |
Current Ratio |
0.81 | 0.24 | 1.08 | 1.47 | 1.98 | 1.47 | 1.04 | 2.72 | 0.33 | 0.67 |
Net Debt/EBITDA |
5.55 | 6.16 | 22.92 | 5.20 | 10.44 | 9.83 | (11.69) | 25.57 | 20.58 | 9.87 |
Debt/Assets |
63.57% | 62.39% | 107.10% | 48.67% | 58.29% | 57.86% | 79.54% | 68.78% | 82.23% | 63.64% |
Debt/Equity |
(2.00) | 3.72 | 17.51 | 4.71 | 5.67 | 5.88 | 14.68 | 231.16 | (17.03) | 123.65 |
Asset Turnover |
0.19 | 0.22 | 0.21 | 0.19 | 0.16 | 0.25 | 0.41 | 0.26 | 0.30 | 0.83 |
Operating CF/Net income |
0.23 | (0.60) | (0.07) | (0.69) | (0.13) | (0.48) | 0.23 | 0.09 | (0.60) | (0.74) |
Capex/Depreciation |
2.66 | (0.43) | (0.06) | 0.72 | (0.15) | (0.05) | (0.11) | (0.41) | (0.25) | 4.08 |
Interest Coverage |
0.63 | 1.25 | (0.13) | 1.04 | 0.83 | 0.95 | (2.70) | (0.30) | 0.06 | 0.62 |
| 47.90% | 20.85% | 39.43% | 6.54% | 18.99% | 19.70% | 28.65% | (101.89%) | 15.78% | (16.73%) | |
| (10.25%) | (7.61%) | (19.20%) | (3.26%) | (8.73%) | (9.53%) | (18.21%) | 60.43% | (5.25%) | 4.75% | |
ROIC |
12.63% | 3.94% | (0.46%) | 5.78% | 2.15% | 2.57% | (7.84%) | (1.32%) | 0.23% | 2.68% |
Return on Tangible Assets |
(19.90%) | (12.95%) | (25.46%) | (6.04%) | (16.80%) | (18.78%) | (33.68%) | 85.83% | (16.17%) | 10.90% |
Average Days of Receivables |
32.12 | 13.72 | 16.08 | 17.46 | 43.60 | 29.33 | 63.90 | 29.84 | 66.93 | 55.10 |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
27.95% | 15.33% | 16.75% | 15.85% | 19.19% | 14.73% | 12.95% | 31.53% | 29.50% | 22.65% |
Intangible Assets out of Total Assets |
0.06 | 0.06 | 0.05 | 0.04 | 0.04 | 0.04 | 0.06 | 0.07 | 0.07 | 0.09 |
Share Based Compensation of Revenue |
4.10% | 1.06% | 0.80% | 0.46% | 0.28% | 1.80% | 0.65% | 2.08% | 0.62% | 0.44% |
Graham Net Nets |
(4.42) | (21.80) | (31.85) | (38.90) | (14.32) | (10.55) | (9.63) | (11.31) | (19.51) | (12.95) |
Graham Number |
67.66 | 55.95 | 94.86 | 22.31 | 62.66 | 62.95 | 81.50 | 27.28 | 21.44 | 0.00 |
Earnings Yield |
(47.45%) | (221.55%) | (763.61%) | (52.64%) | (160.34%) | (130.16%) | (289.00%) | (158.36%) | (110.90%) | 39.06% |
Free Cash Flow Yield |
43.40% | 75.92% | 38.63% | 212.64% | 13.98% | 61.01% | (70.65%) | 70.54% | 48.75% | 191.26% |
Revenue per Share |
16.66 | 15.21 | 13.15 | 11.93 | 10.41 | 15.39 | 20.23 | 9.14 | 9.87 | 18.95 |
Operating CF per Share |
(2.06) | 3.11 | 0.80 | 1.42 | 0.77 | 2.82 | (2.02) | 1.98 | 1.05 | (0.81) |
Capex per Share |
10.18 | (1.34) | (0.20) | 1.56 | (0.27) | (0.07) | (0.16) | (0.51) | (0.29) | 3.25 |
Free Cash Flow per Share |
8.12 | 1.77 | 0.60 | 2.98 | 0.50 | 2.75 | (2.18) | 1.47 | 0.76 | 2.45 |
Cash per Share |
9.44 | 1.68 | 3.87 | 4.76 | 4.44 | 5.68 | 2.20 | 2.23 | 1.32 | 1.66 |
Shareholders Equity per Share |
(22.90) | 10.81 | 3.67 | 6.96 | 6.58 | 6.00 | 2.09 | 0.10 | (1.57) | 0.12 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
(22.90) | 10.81 | 3.67 | 6.96 | 6.58 | 6.00 | 2.09 | 0.10 | (1.57) | 0.12 |
Free Cash Flow |
13.46 | 2.92 | 1.01 | 5.03 | 0.85 | 4.77 | (3.88) | 2.75 | 1.41 | 6.87 |
Working Capital |
(4.80) | (14.79) | 0.84 | 3.24 | 5.13 | 4.08 | 0.49 | 11.28 | (13.59) | (7.87) |
Capital Expenditures |
16.87 | (2.22) | (0.34) | 2.63 | (0.45) | (0.12) | (0.28) | (0.96) | (0.53) | 9.13 |
Net Current Asset Value |
(136.96) | (83.98) | (83.27) | (91.92) | (86.56) | (82.48) | (52.82) | (44.16) | (56.56) | (51.17) |
EV/EBIT |
20.21 | 13.15 | 0.00 | 9.10 | 26.82 | 23.34 | 0.00 | 0.00 | 311.56 | 25.30 |
Capex to Sales |
(0.61) | 0.09 | 0.02 | (0.13) | 0.03 | 0.00 | 0.01 | 0.06 | 0.03 | (0.17) |
Price to Operating Income |
6.86 | 0.75 | 0.00 | 0.43 | 2.63 | 3.09 | 0.00 | 0.00 | 18.00 | 2.16 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.08 | 0.06 | 0.07 | 0.07 | 0.06 | 0.05 | 0.05 | 0.07 | 0.06 | 0.06 |
Cash ROIC |
25.09% | 3.36% | 0.84% | 6.69% | 1.04% | 5.86% | (6.24%) | 5.84% | 2.87% | 14.26% |
Accounts Receivable Turnover |
4.91 | 14.91 | 23.01 | 20.82 | 11.48 | 12.57 | 8.52 | 4.46 | 7.70 | 9.34 |
Accounts Payable Turnover |
0.00 | 0.17 | 0.15 | 0.16 | 0.20 | 2.93 | 5.98 | 2.96 | 3.05 | 7.07 |
Inventory Turnover |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Days of Payables |
0.00 | 2,525.06 | 2,494.93 | 2,042.56 | 1,626.55 | 138.01 | 57.04 | 106.13 | 142.84 | 67.52 |
Days of Inventory on Hand |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 13.09 |
Average Receivables |
5.62 | 1.69 | 0.96 | 0.97 | 1.53 | 2.12 | 4.22 | 3.85 | 2.38 | 5.69 |
Average Payables |
7.45 | 3.71 | 4.37 | 4.03 | 3.35 | 3.38 | 3.52 | 2.89 | 3.09 | 5.34 |
Average Assets |
144.38 | 113.02 | 103.56 | 107.16 | 110.89 | 106.86 | 87.14 | 65.38 | 61.32 | 64.14 |
Average Common Equity |
(30.89) | (41.25) | (50.41) | (53.48) | (51.00) | (51.67) | (55.37) | (38.77) | (20.39) | (18.20) |
Columns are period end dates · fundamentals updated 25 Oct 2026